IA
ABBV icon

IFS Advisors’s AbbVie ABBV Stock Holding History

IFS Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.5K Hold
200
– – 0.02% 60
2025
Q4 		$45.7K Hold
200
– – 0.02% 50
2025
Q3 		$46.3K Hold
200
– – 0.03% 49
2025
Q2 		$37.1K Sell
200
-300
-60% -$55.8K 0.03% 44
2025
Q1 		$105K Hold
500
– – 0.09% 24
2024
Q4 		$88.8K Buy
500
+300
+150% +$55.2K 0.07% 25
2024
Q3 		$39.5K Hold
200
– – 0.03% 34
2024
Q2 		$34.3K Hold
200
– – 0.03% 33
2024
Q1 		$36.4K Buy
+200
New +$34.5K 0.03% 34

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IFS Advisors's ABBV Position: Q1 2026 in Review

IFS Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 200 shares worth $43.5K. The position accounts for 0.02% of the portfolio, ranked #60.

IFS Advisors first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $105K in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • IFS Advisors held 200 shares of AbbVie worth $43.5K as of Q1 2026.
  • IFS Advisors left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.02% of IFS Advisors's portfolio in Q1 2026, its #60 holding.
  • IFS Advisors first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • IFS Advisors's AbbVie position peaked at $105K in Q1 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on IFS Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.